Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Gene therapy refers to the introduction of exogenous normal genes into target cells to correct or compensate for diseases caused by defective and abnormal genes in order to achieve therapeutic goals.
In recent years, gene therapy has been used with increased frequency to treat a variety of rare and incurable diseases, such as cancer and genetic disorders. Increased funding for cellular gene therapy companies in European countries such as the UK is expected to drive the European market at a considerable growth rate. Moreover, European companies are committed to expand product distribution globally by obtaining approvals from several regulatory bodies. China is recognized as a global focus for the development of new therapies. In the current scenario, the number of ongoing clinical trials for gene therapies in China has surpassed the number of trials in the US. The Asia-Pacific gene therapy market is also expected to grow.
Gene therapy can provide a fundamental solution to many difficult conditions such as cancer, and with the increasing research in biotechnology, more gene therapies will be found, which is expected to drive the gene therapy market.
This report elaborates on the current development of the Gene Therapy industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical
Advantagene
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Lentivirus
AAV
Retrovirus & Gammaretrovirus
Modified Herpes Simplex Virus
Adenovirus
Non-viral Plasmid Vector
Application:
Acute Lymphoblastic Leukemia (ALL)
Inherited Retinal Disease
Large B-cell Lymphoma
ADA-SCID
Melanoma (Lesions)
Beta-Thalassemia Major/SCD
Head & Neck Squamous Cell Carcinoma
Peripheral Arterial Disease
Spinal Muscular Atrophy (SMA)
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Gene Therapy Industry Overview
-
1.1.1 Gene Therapy Market Scope and Market Segments
-
1.1.2 Gene Therapy Industry Characteristics
-
1.1.3 Global and China Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Gene Therapy Production Value and Growth Rate (2017-2028)
-
1.2 Global Gene Therapy Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Lentivirus
-
1.2.2 AAV
-
1.2.3 Retrovirus & Gammaretrovirus
-
1.2.4 Modified Herpes Simplex Virus
-
1.2.5 Adenovirus
-
1.2.6 Non-viral Plasmid Vector
-
1.3 Global Gene Therapy Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Acute Lymphoblastic Leukemia (ALL)
-
1.3.2 Inherited Retinal Disease
-
1.3.3 Large B-cell Lymphoma
-
1.3.4 ADA-SCID
-
1.3.5 Melanoma (Lesions)
-
1.3.6 Beta-Thalassemia Major/SCD
-
1.3.7 Head & Neck Squamous Cell Carcinoma
-
1.3.8 Peripheral Arterial Disease
-
1.3.9 Spinal Muscular Atrophy (SMA)
-
1.3.10 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America Gene Therapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Gene Therapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Gene Therapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Gene Therapy Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Gene Therapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Gene Therapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Gene Therapy Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Gene Therapy Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Gene Therapy Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Gene Therapy Industry Porter's Five Forces Model Analysis
-
2.2.3 Gene Therapy Industry PEST Analysis
-
2.3 Gene Therapy Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Gene Therapy Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Gene Therapy Industry
Chapter 3 Global and China Gene Therapy Market, by Manufacturer
-
3.1 Global and China Gene Therapy Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Gene Therapy Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Gene Therapy Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Gene Therapy Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Gene Therapy Market Top 3 Players
Chapter 4 Global and China Gene Therapy Market, by Type (2017-2028)
-
4.1 Gene Therapy Market Trend, by Type
-
4.2 Global Gene Therapy Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Gene Therapy Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Gene Therapy Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Gene Therapy Price Trend, by Type (2017-2028)
-
4.3 China Gene Therapy Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Gene Therapy Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Gene Therapy Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Gene Therapy Price Trend, by Type (2017-2028)
Chapter 5 Global and China Gene Therapy Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Gene Therapy Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Gene Therapy Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Gene Therapy Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Gene Therapy Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Gene Therapy Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Gene Therapy Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Gene Therapy Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Gene Therapy Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Gene Therapy Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Gene Therapy Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Gene Therapy Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Gene Therapy Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Gene Therapy Market Analysis
-
7.1 North America Gene Therapy Market, by Type
-
7.2 North America Gene Therapy Market, by Application
-
7.3 North America Gene Therapy Market Analysis and Forecast, by Country
-
7.3.1 United States Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Gene Therapy Market Analysis
-
8.1 Europe Gene Therapy Market, by Type
-
8.2 Europe Gene Therapy Market, by Application
-
8.3 Europe Gene Therapy Market Analysis and Forecast, by Country
-
8.3.1 Germany Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Gene Therapy Market Analysis
-
9.1 APAC Gene Therapy Market, by Type
-
9.2 APAC Gene Therapy Market, by Application
-
9.3 APAC Gene Therapy Market Analysis and Forecast, by Country
-
9.3.1 China Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Gene Therapy Market Analysis
-
10.1 Latin America, Middle East and Africa Gene Therapy Market, by Type
-
10.2 Latin America, Middle East and Africa Gene Therapy Market, by Application
-
10.3 Latin America, Middle East and Africa Gene Therapy Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Gene Therapy Company Profiles
-
11.1 Sangamo
-
11.1.1 Sangamo Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Sangamo Gene Therapy Product Profiles, Application and Specification
-
11.1.3 Sangamo Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Spark Therapeutics
-
11.2.1 Spark Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Spark Therapeutics Gene Therapy Product Profiles, Application and Specification
-
11.2.3 Spark Therapeutics Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Dimension Therapeutics
-
11.3.1 Dimension Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Dimension Therapeutics Gene Therapy Product Profiles, Application and Specification
-
11.3.3 Dimension Therapeutics Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Avalanche Bio
-
11.4.1 Avalanche Bio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Avalanche Bio Gene Therapy Product Profiles, Application and Specification
-
11.4.3 Avalanche Bio Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Celladon
-
11.5.1 Celladon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Celladon Gene Therapy Product Profiles, Application and Specification
-
11.5.3 Celladon Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Vical
-
11.6.1 Vical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Vical Gene Therapy Product Profiles, Application and Specification
-
11.6.3 Vical Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Advantagene
-
11.7.1 Advantagene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Advantagene Gene Therapy Product Profiles, Application and Specification
-
11.7.3 Advantagene Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Gene Therapy Industry Investment Prospect and Risk Assessment
-
12.1 Gene Therapy Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Gene Therapy Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure China Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Global Gene Therapy Production Value and Growth Rate (2017-2028)
-
Figure China Gene Therapy Production Value and Growth Rate (2017-2028)
-
Figure Global Gene Therapy Market Size and Growth Rate of Lentivirus (2017-2028)
-
Figure Global Gene Therapy Market Size and Growth Rate of AAV (2017-2028)
-
Figure Global Gene Therapy Market Size and Growth Rate of Retrovirus & Gammaretrovirus (2017-2028)
-
Figure Global Gene Therapy Market Size and Growth Rate of Modified Herpes Simplex Virus (2017-2028)
-
Figure Global Gene Therapy Market Size and Growth Rate of Adenovirus (2017-2028)
-
Figure Global Gene Therapy Market Size and Growth Rate of Non-viral Plasmid Vector (2017-2028)
-
Figure Global Gene Therapy Market Size and Growth Rate of Acute Lymphoblastic Leukemia (ALL) (2017-2028)
-
Figure Global Gene Therapy Market Size and Growth Rate of Inherited Retinal Disease (2017-2028)
-
Figure Global Gene Therapy Market Size and Growth Rate of Large B-cell Lymphoma (2017-2028)
-
Figure Global Gene Therapy Market Size and Growth Rate of ADA-SCID (2017-2028)
-
Figure Global Gene Therapy Market Size and Growth Rate of Melanoma (Lesions) (2017-2028)
-
Figure Global Gene Therapy Market Size and Growth Rate of Beta-Thalassemia Major/SCD (2017-2028)
-
Figure Global Gene Therapy Market Size and Growth Rate of Head & Neck Squamous Cell Carcinoma (2017-2028)
-
Figure Global Gene Therapy Market Size and Growth Rate of Peripheral Arterial Disease (2017-2028)
-
Figure Global Gene Therapy Market Size and Growth Rate of Spinal Muscular Atrophy (SMA) (2017-2028)
-
Figure Global Gene Therapy Market Size and Growth Rate of Others (2017-2028)
-
Figure North America Gene Therapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Gene Therapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Gene Therapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Gene Therapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Gene Therapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Gene Therapy Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Gene Therapy Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Gene Therapy Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Gene Therapy Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Gene Therapy Market Share, by Manufacturer in 2021
-
Figure Global and China Gene Therapy Market Share, by Manufacturer in 2022
-
Table Global Gene Therapy Sales Volume, by Type (2017-2028)
-
Table Global Gene Therapy Sales Volume Share, by Type (2017-2028)
-
Figure Global Gene Therapy Sales Volume Share, by Type (2017-2028)
-
Table Global Gene Therapy Sales Value, by Type (2017-2028)
-
Table Global Gene Therapy Sales Value Share, by Type (2017-2028)
-
Figure Global Gene Therapy Price Trend, by Type (2017-2028)
-
Table China Gene Therapy Sales Volume, by Type (2017-2028)
-
Table China Gene Therapy Sales Volume Share, by Type (2017-2028)
-
Figure China Gene Therapy Sales Volume Share, by Type (2017-2028)
-
Table China Gene Therapy Sales Value, by Type (2017-2028)
-
Table China Gene Therapy Sales Value Share, by Type (2017-2028)
-
Figure China Gene Therapy Price Trend, by Type (2017-2028)
-
Table Global Gene Therapy Sales Volume, by Application (2017-2028)
-
Table Global Gene Therapy Sales Volume Share, by Application (2017-2028)
-
Figure Global Gene Therapy Sales Volume Share, by Application (2017-2028)
-
Table Global Gene Therapy Sales Value, by Application (2017-2028)
-
Table Global Gene Therapy Sales Value Share, by Application (2017-2028)
-
Figure Global Gene Therapy Sales Value Share, by Application (2017-2028)
-
Table China Gene Therapy Sales Volume, by Application (2017-2028)
-
Table China Gene Therapy Sales Volume Share, by Application (2017-2028)
-
Figure China Gene Therapy Sales Volume Share, by Application (2017-2028)
-
Table China Gene Therapy Sales Value, by Application (2017-2028)
-
Table China Gene Therapy Sales Value Share, by Application (2017-2028)
-
Figure China Gene Therapy Sales Value Share, by Application (2017-2028)
-
Figure China Gene Therapy Production, Import, Consumption and Export (2017-2022)
-
Figure North America Gene Therapy Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Gene Therapy Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Gene Therapy Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Gene Therapy Production, Import, Consumption and Export (2017-2022)
-
Table North America Gene Therapy Sales Volume, by Type (2017-2028)
-
Table North America Gene Therapy Sales Volume Share, by Type (2017-2028)
-
Figure North America Gene Therapy Sales Volume Share, by Type (2017-2028)
-
Table North America Gene Therapy Sales Volume, by Application (2017-2028)
-
Table North America Gene Therapy Sales Volume Share, by Application (2017-2028)
-
Figure North America Gene Therapy Sales Volume Share, by Application (2017-2028)
-
Figure United States Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure United States Gene Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Canada Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Gene Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Gene Therapy Sales Value and Growth Rate (2017-2028)
-
Table Europe Gene Therapy Sales Volume, by Type (2017-2028)
-
Table Europe Gene Therapy Sales Volume Share, by Type (2017-2028)
-
Figure Europe Gene Therapy Sales Volume Share, by Type (2017-2028)
-
Table Europe Gene Therapy Sales Volume, by Application (2017-2028)
-
Table Europe Gene Therapy Sales Volume Share, by Application (2017-2028)
-
Figure Europe Gene Therapy Sales Volume Share, by Application (2017-2028)
-
Figure Germany Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Gene Therapy Sales Value and Growth Rate (2017-2028)
-
Figure UK Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure UK Gene Therapy Sales Value and Growth Rate (2017-2028)
-
Figure France Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure France Gene Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Italy Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Gene Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Gene Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Spain Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Gene Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Gene Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Poland Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Gene Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Russia Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Gene Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Gene Therapy Sales Value and Growth Rate (2017-2028)
-
Table APAC Gene Therapy Sales Volume, by Type (2017-2028)
-
Table APAC Gene Therapy Sales Volume Share, by Type (2017-2028)
-
Figure APAC Gene Therapy Sales Volume Share, by Type (2017-2028)
-
Table APAC Gene Therapy Sales Volume, by Application (2017-2028)
-
Table APAC Gene Therapy Sales Volume Share, by Application (2017-2028)
-
Figure APAC Gene Therapy Sales Volume Share, by Application (2017-2028)
-
Figure China Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure China Gene Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Japan Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Gene Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Gene Therapy Sales Value and Growth Rate (2017-2028)
-
Figure India Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure India Gene Therapy Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Gene Therapy Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Gene Therapy Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Gene Therapy Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Gene Therapy Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Gene Therapy Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Gene Therapy Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Gene Therapy Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Gene Therapy Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Gene Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Gene Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Gene Therapy Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Gene Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Gene Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Gene Therapy Sales Value and Growth Rate (2017-2028)
-
Table Sangamo Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sangamo Product Profiles, Application and Specification
-
Table Sangamo Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Spark Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Spark Therapeutics Product Profiles, Application and Specification
-
Table Spark Therapeutics Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Dimension Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Dimension Therapeutics Product Profiles, Application and Specification
-
Table Dimension Therapeutics Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Avalanche Bio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Avalanche Bio Product Profiles, Application and Specification
-
Table Avalanche Bio Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Celladon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Celladon Product Profiles, Application and Specification
-
Table Celladon Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Vical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Vical Product Profiles, Application and Specification
-
Table Vical Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Advantagene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Advantagene Product Profiles, Application and Specification
-
Table Advantagene Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
